Xilio Therapeutics, Inc. — Form 10-Q
Filed August 12, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 22/100
What the filing says
Xilio amended its 2022 Inducement Stock Incentive Plan (effective June 10, 2026) to establish a 373,555-share pool for grants to newly hired employees and those returning after bona fide breaks. The plan permits options, SARs, restricted stock, RSUs, and other equity awards, with standard vesting, repricing protections, and Section 409A compliance provisions. No specific new grants or material dollar amounts are disclosed in this document; it is the plan framework itself.
Why this rating
Routine equity plan amendment. Share pool (373,555 shares) is ~1% of $34.9M market cap at typical valuations. No new grants or counterparties named; document is boilerplate plan terms.
See more from August 12, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.